RF
GSK icon

Robinswood Financial’s GSK GSK Stock Holding History

Robinswood Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1K Buy
287
+2
+0.7% +$106 ﹤0.01% 259
2026
Q1 		$15.8K Buy
285
+2
+0.7% +$108 0.01% 248
2025
Q4 		$13.9K Hold
283
– – ﹤0.01% 250
2025
Q3 		$12.2K Hold
283
– – ﹤0.01% 244
2025
Q2 		$10.9K Hold
283
– – ﹤0.01% 249
2025
Q1 		$11K Buy
+283
New +$10.4K ﹤0.01% 239
2024
Q3 		– Sell
-174
Closed -$6.7K – 376
2024
Q2 		$6.7K Buy
+174
New +$7.32K ﹤0.01% 244

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Robinswood Financial's GSK Position: Q2 2026 in Review

Robinswood Financial increased its GSK (GSK) stake by 0.7% in Q2 2026, buying an estimated $106 and bringing the position to 287 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #259.

Robinswood Financial first reported a position in GSK in Q2 2024 and has held it in 7 quarters since. The position peaked at $15.8K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Robinswood Financial held 287 shares of GSK worth $15.1K as of Q2 2026.
  • Robinswood Financial bought 2 GSK shares in Q2 2026, an estimated $106.
  • GSK made up ﹤0.01% of Robinswood Financial's portfolio in Q2 2026, its #259 holding.
  • Robinswood Financial first reported a position in GSK in Q2 2024 and has held it in 7 quarters since.
  • Robinswood Financial's GSK position peaked at $15.8K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Robinswood Financial's 13F filing for Q2 2026, filed 15 Jul 2026.